Item 7.01. Regulation FD Disclosure.

On March 31, 2020, Amgen Inc. posted on its website at https://www.amgen.com/media/our-perspective/amgen-update-regarding-covid-19/ an Amgen Update Regarding COVID-19 for Media (the "COVID-19 Perspective"). A copy of the COVID-19 Perspective is attached hereto as Exhibit 99.1 and incorporated into this Item 7.01 by reference. The information contained in this Item 7.01 and Exhibit 99.1 shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of such section, nor will such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as may be expressly set forth by specific reference in such filing.

Item 9.01. Financial Statements and Exhibits.




d)  Exhibits

 Exhibit
   No.           Description

   99.1            Amgen Update Regarding COVID-19 for Media, dated March 31, 2020.


   104           Cover Page Interactive File (the cover page tags are embedded within
                 the Inline XBRL document).

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses